etoposide has been researched along with Carcinoid Heart Disease in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baudin, E; Caplin, ME; Ferolla, P; Filosso, P; Garcia-Yuste, M; Lim, E; Oberg, K; Pelosi, G; Perren, A; Rossi, RE; Travis, WD | 1 |
Kvols, LK | 1 |
2 review(s) available for etoposide and Carcinoid Heart Disease
Article | Year |
---|---|
Pulmonary neuroendocrine (carcinoid) tumors: European Neuroendocrine Tumor Society expert consensus and recommendations for best practice for typical and atypical pulmonary carcinoids.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bronchoscopy; Carboplatin; Carcinoid Heart Disease; Carcinoid Tumor; Cisplatin; Dacarbazine; Etoposide; Europe; Humans; Lung Neoplasms; Pneumonectomy; Positron-Emission Tomography; Receptors, Somatostatin; Societies, Medical; Temozolomide; Tomography, X-Ray Computed; Ultrasonography | 2015 |
Metastatic carcinoid tumors and the malignant carcinoid syndrome.
Topics: Biomarkers, Tumor; Carcinoid Heart Disease; Carcinoid Tumor; Cisplatin; Combined Modality Therapy; Cyproheptadine; Echocardiography; Etoposide; Humans; Interferon Type I; Magnetic Resonance Imaging; Malignant Carcinoid Syndrome; Neoplasm Metastasis; Receptors, Somatostatin; Recombinant Proteins | 1994 |